Today on MedNet21, we're going to discuss Latest Discoveries in Alzheimer’s Disease.

This presentation targets general neurologists as well as family physicians and general practitioners. Given the title, the discussion spans clinical and scientific knowledge. This presentation covers the following areas:

- An overview of AD pathology
- Review of fluid (CSF and blood) biomarkers for AD
- Knowledge of the new biomarker-based definition of the disease which replaces clinical definition in
   research settings
- A review of the new FDA-approved anti-amyloid treatment aducanumab including its mechanism of     action, clinical efficacy, and potential side-effects
- Update on new approaches to biomarker and drug discovery

Physicians have a deficit of knowledge in managing complex ocular disease.  The Havener Eye Institute Retina Case Forum 2021 will focus on preferred practice patterns as endorsed by the American Academy of Ophthalmology.  There will also be an opportunity to discuss unique cases in a forum of clinicians in order to advance the medical knowledge of the group as a whole.  A variety of experience will be present from resident to attending physicians.  The goal is to leverage the knowledge and experience of various experts with the variety of experiences from the group of physicians present.  This will allow those in attendance to further their knowledge to best serve their own patients.